Skip to content

Clinical trials

Phase 4 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 4 Clear all

225 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
200310
200413
200513
200612
200712
200824
200915
201012
20117
20129
201311
20149
20156
201610
20173
201811
20196
20204
20215
20222
20234
20245
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed153
Unknown status25
Recruiting16
Terminated15
Withdrawn10
Not yet recruiting4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company23
Massachusetts General Hospital23
Children's Hospital Medical Center, Cincinnati7
Shire7
Icahn School of Medicine at Mount Sinai5
NYU Langone Health5
Federal University of Rio Grande do Sul4
Florida International University4
Hospital de Clinicas de Porto Alegre4
JPM van Stralen Medicine Professional3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity225
Substance-Related Disorders9
Autistic Disorder6
Oppositional Defiant Disorder6
Conduct Disorder5
Spasm5
Autism Spectrum Disorder4
Dyslexia4
Anxiety Disorders3
Asperger Syndrome3

Trials

Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.

125 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.